Please select a country
- Česká republika
- CeramTec GmbH
- CeramTec-ETEC GmbH
- Emil Müller GmbH
Chief Executive Officer (CEO)
Henri Steinmetz was appointed CEO of the CeramTec Group on March 14, 2016 and is also responsible for the Industrial Applications Segment. He was last active at Belgium-based Ruetgers NV, a leading European manufacturer of chemical raw materials, where he was President and CEO since 2009. In this position, Henri Steinmetz significantly improved the growth and profitability of the group and expanded the business into the United States and Russia. Before joining Ruetgers, he was from 2004 to 2008 a member of the executive board of Sulzer AG, a global industrial group based in Winterthur, Switzerland, and also President of the Sulzer Metco Division. Other stations in Henri Steinmetz’s career include Great Lakes Chemicals in Indianapolis, Indiana (USA), where he was Corporate Executive Vice President and President of the Polymer Stabilizers Division, M.A. Hanna Company in Cleveland, Ohio (USA), where he was Director of Business Development Europe, and General Electric USA/Netherlands, where he had various management positions. He holds a Master of Sciences in Metallurgy from Clausthal University of Technology and an MBA from INSEAD, Fontainebleau, France.
Member of the Executive Board (Finance)
Effective 1 October 2014, Dominique Janbon was appointed to the Executice Board of the CeramTec Group as Chief Financial Officer. Mr. Janbon joins from medical technology company Gambro AB, where he was CFO and Senior Vice President since 2012. During his time at Gambro he was part of the senior management team which implemented a new growth strategy for the company. In his role, he contributed significantly to the successful transformation of the company and later to the US$ 4bn sale of the company to Baxter. Dominique Janbon previously held senior positions in finance and commercial development at global pharmaceutical companies Amgen International and Sanofi S.A. Dominique Janbon holds a Master of Sciences in Accounting and Finance from the London School of Economics and a Master degree in Economics, Management and Finance from the Institut d’Etudes Politiques de Paris. He is a French national.
Member of the Executive Board (COO Medical Applications Segment)
Dr. Hadi Saleh was appointed to CeramTec’s Executive Board on July 1, 2015 and is responsible for the Medical Applications Segment as its Chief Operating Officer. Dr. Saleh worked in the medical technology sector, where as Senior Vice President of Biomet Inc. and President of Biomet International he was previously responsible for all Bionet product lines worldwide outside of the US and Europe. In addition, he played a leading role in the Zimmer Holdings acquisition of Bioment Inc. this June. Since 2001, Dr. Saleh has held a number of positions at Biomet, first at Biomet Germany, then Biomet Europe and finally at the parent company, Biomet Inc. in Warsaw, IN in the United States. Prior to this he studied and earned his doctorate at the universities in Frankfurt am Main and Mainz, worked as an orthopedist at St. Josef’s Hospital in Wiesbaden and at the University Clinic in Heidelberg and was a Senior Consultant at GAIA in Hamburg.
Please click on the button “Contacts” to the right, to get a list with the personal and direct responsible contacts within the CeramTec Group.